Novavax, Inc. (NVAX)
NASDAQ: NVAX · Real-Time Price · USD
10.14
-1.05 (-9.38%)
At close: Feb 27, 2026, 4:00 PM EST
10.11
-0.03 (-0.30%)
After-hours: Feb 27, 2026, 4:33 PM EST
Novavax Employees
Novavax had 952 employees as of December 31, 2024. The number of employees decreased by 591 or -38.30% compared to the previous year.
Employees
952
Change (1Y)
-591
Growth (1Y)
-38.30%
Revenue / Employee
$1,180,125
Profits / Employee
$462,502
Market Cap
1.65B
Employees Chart
Employees History
Related Stocks
| Company Name | Employees |
|---|---|
| Sarepta Therapeutics | 1,372 |
| Syndax Pharmaceuticals | 270 |
| Zymeworks | 263 |
| Aurinia Pharmaceuticals | 130 |
| Innoviva | 127 |
| Pharvaris | 118 |
| Enliven Therapeutics | 65 |
| Nektar Therapeutics | 61 |
NVAX News
- 2 hours ago - What's Going On With Novavax Stock On Friday? - Benzinga
- 4 hours ago - Novavax: The Bear Case Is Broken, But The Bull Case Needs More Proof - Seeking Alpha
- 1 day ago - Novavax to Participate in Upcoming Investor Conferences - PRNewsWire
- 1 day ago - Novavax, Inc. (NVAX) Q4 2025 Earnings Call Transcript - Seeking Alpha
- 1 day ago - COVID-19 Vaccine Maker Novavax Swings To Profit As Sales Climb - Benzinga
- 1 day ago - Novavax raises 2026 adjusted revenue outlook on strength in vaccine deals - Reuters
- 1 day ago - Novavax Reports Fourth Quarter and Full Year 2025 Financial Results and Operational Highlights - PRNewsWire
- 8 days ago - Novavax to Report Fourth Quarter and Full Year 2025 Financial Results on February 26, 2026 - PRNewsWire